PUREVAX Feline 3/RabiesThis page contains information on PUREVAX Feline 3/Rabies for veterinary use.
The information provided typically includes the following:
- PUREVAX Feline 3/Rabies Indications
- Warnings and cautions for PUREVAX Feline 3/Rabies
- Direction and dosage information for PUREVAX Feline 3/Rabies
PUREVAX Feline 3/RabiesThis treatment applies to the following species:
Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Vaccine
Modified Live Virus, Canarypox Vector
DESCRIPTION: PUREVAX® Feline 3/Rabies contains a nonadjuvanted lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses; recombinant vectored rabies vaccine; plus a sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to rabies. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
INDICATIONS: PUREVAX® Feline 3/Rabies is recommended for the vaccination of healthy cats 8 weeks of age and older for prevention of disease due to feline rhinotracheitis, calici, panleukopenia, and rabies viruses.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy cats. For primary vaccination of cats younger than 12 weeks of age, revaccinate every 3 to 4 weeks with the last dose given at or over 12 weeks of age. For primary vaccination of cats 12 weeks or older, revaccinate with a second 1 ml dose of this product or Code 16D8.21 (Purevax® Feline 3), 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn this container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
PUREVAX is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, (Québec), H9X 3V1, Canada
25 x 1 Dose, Lyophilized
25 x 1 mL, Sterile Water
NAC No.: 11110524
Merial is now part of Boehringer Ingelheim
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the PUREVAX Feline 3/Rabies information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-11-28